Duopharma Biotech Bhd Net Asset Quality Index
Duopharma Biotech Bhd net asset quality index. Duopharma Biotech Bhd (7148) has a Net Asset Quality Index of 53.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RM1.46 Billion minus total liabilities of RM671.59 Million yields net assets of RM786.14 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Duopharma Biotech Bhd (7148) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Duopharma Biotech Bhd (2006–2025)
Net asset quality index of Duopharma Biotech Bhd from 2006 to 2025. This chart shows how Duopharma Biotech Bhd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of June 2026, the index stands at 53.9%, representing net assets of RM786.14 Million against total assets of RM1.46 Billion MYR. Check strategic asset allocation of Duopharma Biotech Bhd to assess the company's strategic physical and investment asset allocation.
Duopharma Biotech Bhd Net Asset Quality Index by Year (2006–2025)
Duopharma Biotech Bhd net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for Duopharma Biotech Bhd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 7148 stock market capitalisation.
| Year | Quality Index | Net Assets (MYR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 52.3% | RM757.62 Million | RM1.45 Billion | RM690.68 Million | ▲ +0.8 pp |
| 2024 | 51.5% | RM709.15 Million | RM1.38 Billion | RM667.85 Million | ▲ +0.4 pp |
| 2023 | 51.1% | RM687.12 Million | RM1.35 Billion | RM658.01 Million | ▼ -2.5 pp |
| 2022 | 53.6% | RM655.22 Million | RM1.22 Billion | RM566.70 Million | ▲ +0.0 pp |
| 2021 | 53.6% | RM624.00 Million | RM1.16 Billion | RM540.13 Million | ▼ -7.2 pp |
| 2020 | 60.8% | RM643.82 Million | RM1.06 Billion | RM414.61 Million | ▲ +3.2 pp |
| 2019 | 57.6% | RM529.75 Million | RM919.80 Million | RM390.05 Million | ▲ +0.1 pp |
| 2018 | 57.5% | RM481.04 Million | RM836.38 Million | RM355.34 Million | ▼ -10.5 pp |
| 2017 | 68.0% | RM479.87 Million | RM705.24 Million | RM225.38 Million | ▼ -0.7 pp |
| 2016 | 68.7% | RM454.52 Million | RM661.46 Million | RM206.95 Million | ▼ -2.3 pp |
| 2015 | 71.0% | RM449.72 Million | RM633.45 Million | RM183.73 Million | ▼ -16.0 pp |
| 2014 | 87.0% | RM193.63 Million | RM222.48 Million | RM28.85 Million | ▼ -1.8 pp |
| 2013 | 88.8% | RM182.65 Million | RM205.65 Million | RM23.00 Million | ▲ +2.7 pp |
| 2012 | 86.1% | RM170.50 Million | RM198.03 Million | RM27.53 Million | ▲ +2.8 pp |
| 2011 | 83.3% | RM164.44 Million | RM197.52 Million | RM33.08 Million | ▲ +2.9 pp |
| 2010 | 80.3% | RM157.87 Million | RM196.48 Million | RM38.61 Million | ▼ -2.0 pp |
| 2009 | 82.3% | RM142.74 Million | RM173.36 Million | RM30.63 Million | ▼ -4.5 pp |
| 2008 | 86.8% | RM130.55 Million | RM150.38 Million | RM19.83 Million | ▼ -2.9 pp |
| 2007 | 89.7% | RM114.21 Million | RM127.33 Million | RM13.12 Million | ▼ -1.8 pp |
| 2006 | 91.5% | RM145.43 Million | RM159.01 Million | RM13.58 Million | — |